- Scientific Industries posted a net loss of $1.22 million for fiscal 2025, narrowing from a net loss of $6.45 million a year earlier.
- Revenue rose 5.4% to $5.05 million.
- Gross margin fell 16 percentage points to 25.8% due to inventory write-offs in the bioprocessing segment.
- Other income climbed to $6.11 million on a $5.26 million gain from the sale of the Genie product line.
- Management said cash from the Genie sale and related post-sale agreements should fund operations for at least one year from issuance of the financial statements.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Scientific Industries Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001654954-26-003102), on March 31, 2026, and is solely responsible for the information contained therein.

